Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM) Fundamentals

Cardium Therapeutics is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering and other economic monetizations. Cardium's current medical opportunities portfolio, which is focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Health Sciences healthy lifestyle product platform. The Company's lead commercial product Excellagen(R) topical gel for wound care management, has recently received FDA clearance for marketing and sale in the United States. Cardium's lead clinical development product candidate Generx(R) is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio.
Share Info
Market Cap$ 65
Shares Authorized200,000,000
Shares Outstanding64,931,888
Shares Outstanding Date08/28/2021
Shareholder Count100
Shareholder Count Date12/29/2016
Float Date-
Short Interest99
Short Interest Date05/31/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorMarcum LLP
Auditor Address730 Third Ave
New York, New York 10017
Auditor Website
IR FirmMission Investor Relations
IR Firm Address3645 Marketplace Blvd.
Suite 130-280
Atlanta, Georgia 30344
IR Firm Website
Legal CounselSheppard, Mullin, Richter & Hampton LLP
Legal Counsel Address12275 El Camino Real
Suite 200
San Diego, California 92130
Legal Counsel Website-
Fiscal Year End12/31
ADR Ratio-
Transfer AgentComputershare U.S.
Transfer Agent Address150 Royall Street
Canton, MA 02021
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:CRXM
OTC Market TierExpert Market
Security TypeCommon Stock
CIK Number0000772320
Address11230 Sorrento Valley Rd.
Suite 220
San Diego, California 92121
Phone(858) 414-1477
Fax #-
SIC Code / Description2836 / Biological products, except diagnostic
Key ExecutivesCSO - Ronald Shebuski
Dir. - Kaushik Vyas
Dir. - Murray Hutchinson
President - Christopher Reinhard
Business Affairs - Tracy Kent
Chairman - James Grainer
IR - Bonnie Ortega
Corporate Controller - Mira Habel
COO - Lois Chandler
Number of Employees15
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year2003

Your Recent History
Taxus Card..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.